Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis

ClinicalTrials.gov ID: NCT05152563

Public ClinicalTrials.gov record NCT05152563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of Subcutaneous AK002 in Subjects With Moderate to Severe Eosinophilic Gastritis and/or Eosinophilic Duodenitis

Study identification

NCT ID
NCT05152563
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allakos Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • AK002 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2021
Primary completion
Jan 19, 2022
Completion
Jan 19, 2022
Last update posted
Mar 2, 2023

2021 – 2022

United States locations

U.S. sites
76
U.S. states
31
U.S. cities
73
Facility City State ZIP Site status
Allakos Investigational Site Birmingham Alabama 35205
Allakos Investigational Site Gilbert Arizona 85234
Allakos Investigational Site Phoenix Arizona 85021
Allakos Investigational Site Scottsdale Arizona 85250
Allakos Investigational Site Chula Vista California 91910
Allakos Investigational Site Long Beach California 90808
Allakos Investigational Site Ventura California 93003
Allakos Investigational Site Walnut Creek California 94598
Allakos Investigational Site Bristol Connecticut 06010
Allakos Investigational Site Brandon Florida 33511
Allakos Investigational Site Edgewater Florida 32132
Allakos Investigational Site Jacksonville Florida 32256
Allakos Investigational Site Kissimmee Florida 34741
Allakos Investigational Site Miami Florida 33125
Allakos Investigational Site New Port Richey Florida 34653
Allakos Investigational Site Ponte Vedra Florida 32081
Allakos Investigational Site Sunrise Florida 33351
Allakos Investigational Site Tampa Florida 33603
Allakos Investigational Site Tampa Florida 33612
Allakos Investigational Site Atlanta Georgia 30342
Allakos Investigational Site Sandy Springs Georgia 30328
Allakos Investigational Site Chicago Illinois 60611
Allakos Investigational Site Iowa City Iowa 52242
Allakos Investigational Site Kansas City Kansas 66160
Allakos Investigational Site Crowley Louisiana 70526
Allakos Investigational Site Shreveport Louisiana 71105
Allakos Investigational Site Glen Burnie Maryland 21061
Allakos Investigational Site Boston Massachusetts 02111
Allakos Investigational Site Boston Massachusetts 02215
Allakos Investigational Site Ann Arbor Michigan 48104
Allakos Investigational Site Wyoming Michigan 49519
Allakos Investigational Site Rochester Minnesota 55905
Allakos Investigational Site Bay Saint Louis Mississippi 63106
Allakos Investigational Site Flowood Mississippi 39232
Allakos Investigational Site Kansas City Missouri 64108
Allakos Investigational Site Kalispell Montana 59901
Allakos Investigational Site Reno Nevada 89511
Allakos Investigational Site Lebanon New Hampshire 03756
Allakos Investigational Site Florham Park New Jersey 07932
Allakos Investigational Site Freehold New Jersey 07728
Allakos Investigational Site Great Neck New York 11023
Allakos Investigational Site New York New York 10029
Allakos Investigational Site Chapel Hill North Carolina 27599
Allakos Investigational Site Charlotte North Carolina 28204
Allakos Investigational Site Concord North Carolina 28027
Allakos Investigational Site Durham North Carolina 27710
Allakos Investigational Site Raleigh North Carolina 27607
Allakos Investigational Site Winston-Salem North Carolina 27157
Allakos Investigational Site Cincinnati Ohio 45229
Allakos Investigational Site Columbus Ohio 43210
Allakos Investigational Site Dayton Ohio 45415
Allakos Investigational Site Mentor Ohio 44060
Allakos Investigational Site Springboro Ohio 45066
Allakos Investigational Site Westlake Ohio 44145
Allakos Investigational Site Oklahoma City Oklahoma 73102
Allakos Investigational Site Philadelphia Pennsylvania 19104
Allakos Investigational Site Greenwood South Carolina 29646
Allakos Investigational Site Chattanooga Tennessee 37421
Allakos Investigational Site Germantown Tennessee 38138
Allakos Investigational Site Hixson Tennessee 37343
Allakos Investigational Site Nashville Tennessee 37212
Allakos Investigational Site Austin Texas 78757
Allakos Investigational Site El Paso Texas 79905
Allakos Investigational Site Fort Worth Texas 76104
Allakos Investigational Site Lubbock Texas 79410
Allakos Investigational Site San Antonio Texas 78229
Allakos Investigational Site Southlake Texas 76092
Allakos Investigational Site Webster Texas 77598
Allakos Investigational Site Wichita Falls Texas 76301
Allakos Investigational Site Ogden Utah 84405
Allakos Investigational Site Riverton Utah 84065
Allakos Investigational Site Salt Lake City Utah 84112
Allakos Investigational Site Sandy City Utah 84092
Allakos Investigational Site Fairfax Virginia 22031
Allakos Investigational Site Seattle Washington 98115
Allakos Investigational Site Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05152563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05152563 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →